Although our losers outnumbered our winners last week, our model portfolio year-to-date gain nudged up 1% to 18% due to decent gains in AVSO.ob and IYXI.ob. MIVA is still our biggest dog, followed by Linn.ob, DWCH, PDLI and then INFT. Last week we had 2 up, 8 down and 1 even. Since the start of the year we are 9 up and 5 down. No buys or sells this past week.
Our model portfolio based on the stocks in this Blog is up 18% so far this year (up 1% from last week). This model portfolio assumes $10,000 invested in each stock, less $10 commission each way (TD Ameritrade rate).
CAW-(Buy price $9.45, Valuation $18.40). Closed down $.02 for the week at $9.73. Yield about 3%. A group called Costa Brava Partnership is offering to buy the Class A stock at a “substantial premium”. The company has rejected this offer. The company is “in-play”. CB owns 7.9% of the stock. No news last week on anything. Up 3% so far. HOLD.
QADI-(Buy price $6.93, Valuaton $11.86). Closed at $7.60, down $.03. Up 10% so far. HOLD.
PDLI-(Buy price $19.31, Valuation > $30)–Closed at $17.44, down $.93 from last week. Now down 10%. PDLI announced earnings last week. GAAP loss, Non-GAAP profit. They are now generating $200 million a year in royalties which alone is almost worth the current market cap. They lost one clinical candidate that they acquired last year–don’t see this as a big deal. Big drugs in the pipeline, royalties are growing. This is still a BUY.
MIVA-(Buy price $3.80, Valuation $9.10). MIVA closed at $2.83, down $.11 from last week. Now down 26% on this one. HOLD.
Datawatch-(Buy price $3.66, Valuation $7.63 (was $9.31). Closed at $2.96, down $.09 from last week, still a loser–down 19%. HOLD.
Inforte-(Buy price $4.11, Valuation $6.86 (was $7.32). Down $.25 to $4.00 last week. Still has $2.52 per share in cash and valuation only fell a little, but lowering our price objective to $5.50. Now down 3%. BUY.
Linn.ob-(Buy price $.36, Valuation $.66 (was $.79). Closed at $.29, even on the week. Linn announced earnings last week, had a small loss of about $150,000, excluding special items. Volume in the stock soared last week and we saw some sizable bids (like 80,000 shares) which is encouraging. Still trading at less than 50% of our current valuation. Down 19% YTD. HOLD until we get some revenue growth and stop losing money.
OPTO.ob-(Buy price $1.25, Valuation $2.88). Closed at $1.30, down $.10 from last week. Now up 4% to date. HOLD.
AVSO.ob-(Buy price $1.19, Valuation $3.81). Stock rebounded last week to $1.89, up $.26 from $1.53. Now only up 59%. Not as cheap as last week, but still only trading at 50% of our valuation. BUY.
CTIG.ob-(Buy price $.27 ask, Valuation $.82). Ask price fell to $.42 (down $.02) last week. Closed at $.42. Cash is $.28 per share. Up 56% (based on asked price). HOLD.
IYXI.ob-(Buy price $1.91, Valuation–over $3.00). Closed up $.11 from last week at $2.60, up 36% so far. HOLD